Latest Breaking News On - Ironwood pharmaceuticals - Page 2 : comparemela.com

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLin changRegion flamandeNew yorkJulie khlevnerChristopherv almarioKishorer iyerGerard greigLos angelesAstrid verbiestCenter trialUniversity of leuvenCedars sinai medical centerExchange commissionDrug administrationTranslational research center

COUR Pharmaceuticals Appoints Paul M Peloso, MD, as Chief Medical Officer

COUR Pharmaceuticals Appoints Paul M Peloso, MD, as Chief Medical Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJohnj puisisBrian bockPaulm pelosoOwen blaschakMcmaster universityAcelyrin incPharmaceuticals appoints paulm pelosoEuropean medicines agencyIronwood pharmaceuticalsTakeda pharmaceuticalsUniversity of calgaryAppoints paulChief medicalChief medical officerHorizon therapeutics

STARS: Apraglutide Reduces Parenteral Support in Patients with Stoma, Colon-In-Continuity

New STARS data were presented in a late-breaking abstract at DDW and build upon positive topline results for clinical responder rates and reductions in parenteral support.

District of columbiaUnited statesMichael shetzlineKishore iyerIronwood pharmaceuticalsDrug administrationMount sinaiDigestive disease weekMount sinai hospitalNew drug applicationAcute graft versus host disease

US$16 33: That s What Analysts Think Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Is Worth After Its Latest Results

US$16 33: That s What Analysts Think Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Is Worth After Its Latest Results
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Ironwood pharmaceuticalsIronwood pharmaceutical

Ironwood Pharmaceuticals, Inc Revised Earnings Guidance for Its Fiscal Year 2024

Ironwood Pharmaceuticals, Inc Revised Earnings Guidance for Its Fiscal Year 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Ironwood pharmaceuticals incIronwood pharmaceuticalsFiscal year